Table 2.
Healthy Controls | Diseased Controls | P Value(t and U Tests) | Combined Controls | All IgAN Patients | P Value (t and U Tests) | |
---|---|---|---|---|---|---|
Patients (n) | 30 | 30 | 60 | 97 | ||
IgA (mg/ml) | 2.20 (0.76) | 2.01 (0.81) | NS | 2.10 (0.78) | 2.88 (1.38) | 0.0001 |
2.09 (0.75–4.12) | 1.98 (0.79–3.85) | NS | 2.03 (0.75–4.12) | 2.68 (0.49–8.01) | 0.0003 | |
Gd-IgA1 (% HAA) | 31.3 (9.1) | 36.1 (15.3) | NS | 33.7 (12.7) | 33.1 (12.4) | NS |
29.5 (15.4–57.0) | 31.3 (15.9–86.5) | NS | 30.8 (15.4–86.5) | 31.5 (10.0–76.5) | NS | |
Gd-IgA1 (U/ml) | 68.2 (26.0) | 71.5 (41.1) | NS | 69.9 (34.1) | 92.6 (49.4) | 0.002 |
65.4 (16.7–112.3) | 62.0 (25.3–184.3) | NS | 63.4 (16.7–184.3) | 84.4 (10.0–267.5) | 0.003 | |
IgG (mg/ml) | 11.01 (2.64) | 9.94 (4.05) | NS | 10.47 (3.43) | 10.32 (3.79) | NS |
10.54 (6.69–18.41) | 9.81 (4.88–21.58) | NS | 9.92 (4.88–21.58) | 10.00 (1.33–25.77) | NS | |
IgG autoantibody (OD/0.5 µg) | 1.172 (0.242) | 1.300 (0.304) | NS (0.08) | 1.236 (0.280) | 1.483 (0.643) | 0.006 |
1.195 (0.85–1.54) | 1.272 (0.76–2.00) | NS | 1.255 (0.76–2.00) | 1.490 (0.63–3.01) | 0.07 (NS) | |
IgG autoantibody (U/ml) | 25.60 (7.28) | 25.16 (10.58) | NS | 25.38 (9.01) | 30.79 (19.04) | 0.04 |
24.34 (14.88– 41.96) | 24.55 (12.04–60.97) | NS | 24.40 (12.04–60.97) | 26.03 (5.72–91.62) | NS | |
IgA autoantibody (OD/1 µg) | 0.549 (0.234) | 0.770 (0.638) | NS (0.08) | 0.660 (0.489) | 0.748 (0.451) | NS |
0.458 (0.29–1.13) | 0.556 (0.24–2.84) | NS | 0.493 (0.24–2.84) | 0.589 (0.21–2.31) | NS (0.06) | |
IgA autoantibody (U/ml) | 1.29 (0.91) | 1.55 (1.37) | NS | 1.42 (1.16) | 2.33 (2.02) | 0.002 |
0.93 (0.28–3.45) | 0.90 (0.19–5.99) | NS | 0.91 (0.19–5.99) | 1.78 (0.12–10.63) | 0.002 |
Data are mean (SD) or median (range). NS, not statistically significant.